Uncategorized

United Therapeutics Corporation, a public benefit corporation, announced its financial results for the quarter ended March 31, 2023.

Photocure ASA will announce the first quarter 2023 financial results on Wednesday 10 May 2023 at 08:00 CEST and will present a live webcast at 14:00 CEST the same day.

Innate Pharma SA announced three abstracts including Innate’s product candidates have been accepted for the American Society for Clinical Oncology 2023 Annual Meeting, taking place June 2-6, 2023 in Chicago, IL. One abstract for SAR’579, currently developed by Sanofi, has been selected for oral presentation.

En este Short averiguaremos si los tests de inteligencia son realmente útiles y para qué.     …

Lytix Biopharma AS is pleased to announce that Dr Øystein Rekdal, CEO in Lytix Biopharma, will give an oral presentation at the `Frontiers in Cancer Immunotherapy 2023′ conference, which is taking place in New York, USA.

Sensorion announces that the Company’s shareholders are invited to participate in the Combined General Meeting, to be held on Wednesday, May 24, 2023, at 2 pm CET in the premises of the hotel Square Louvois, located at 12, rue de Louvois, 75002, Paris, France.

IRLAB Therapeutics AB announced that IRLAB has been made aware that Ipsen’s 2022 Universal Registration Document, published on April 6, 2023, contains incorrect information that the development and commercialization rights for mesdopetam have been transferred back to IRLAB.

Occlutech Holding AG is a leading specialist provider of minimally invasive structural heart implants.

IRLAB Therapeutics AB announced that the company will hold a presentation in conjunction with the publication of the interim report for the period January-March 2023.

Innate Pharma SA, announced that the Company will hold a conference call on Wednesday, May 10, 2023 at 2 p.m. CEST / 8 a.m. EDT, to give an update on business progress during the first quarter of 2023.